Luca Bertamini, MD^1*, Cathelijne Fokkema, MD^1*, Paula Rodríguez-Otero, MD, PhD^2*, Mark van Duin, PhD^1*, Niels W.C.J. Van De Donk, MD³, Mattia D'Agostino, MD^4*, Evangelos Terpos, MD, PhD⁵, Diego Vieyra, PhD^6*, Ricardo M. Attar, PhD^6*, Anna Sitthi-Amorn^7*, Robin Carson, MD⁷, Michel Delforge^8*, Christoph Driessen⁹, Roman Hajek, MD, PhD¹⁰, Mario Boccadoro, MD¹¹, Hermann Einsele, MD¹², Annette Vangsted^13*, Vincent H.J. Van Der Velden, PhD^14*, Fredrik Schjesvold, MD, PhD¹⁵, Artur Jurczyszyn^16*, Meral Beksac, MD^17,18, Andrew Spencer, MBBS^19*, Annemiek Broijl, PhD²⁰, Tom Cupedo, PhD^1*, Philippe Moreau, MD, PhD^21* and Pieter Sonneveld, MD¹

¹Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
²Clinica Universidad de Navarra, Madrid, Spain
³Cancer Center Amsterdam, VU University Medical Center, Amsterdam, Netherlands
⁴Division of Hematology, AOU Città della Salute e della Scienza di Torino, University of Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy
⁵Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Drosia, Attiki, Greece
⁶Janssen Research & Development, Spring House, PA
⁷Janssen Research & Development, LLC, Spring House, PA
⁸Universitair Ziekenhuis (UZ) Leuven, Leuven, Belgium
⁹Cantonal Hospital St. Gallen, St. Gallen, Switzerland
¹⁰University Hospital Ostrava and University of Ostrava, Ostrava, Czech Republic
¹¹European Myeloma Network, EMN, Italy
¹²Division of Hematology, University Hospital of Wurzburg, Wurzburg, Germany, Würzburg, DEU
¹³Rigshospitalet, Copenhagen, Denmark
¹⁴Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands
¹⁵Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway
¹⁶Jagiellonian University Medical College, Kraków, Poland
¹⁷Department of Hematology, Ankara University Faculty of Medicine, Department of Hematology, Ankara, Turkey
¹⁸Ankara Liv Hospital, Istinye University, Ankara, Turkey
¹⁹Alfred Health-Monash University, Melbourne, VIC, Australia
²⁰Erasmus MC Cancer Institute, Rotterdam, Netherlands
²¹University Hospital Hôtel-Dieu, Nantes, France

Nayda Bidikian, MD^1,2,3*, Francesco Corrado, MD^1,2,3*, Romanos Sklavenitis-Pistofidis, MD^1,2,3, Yoshinobu Konishi, MD, PhD^1,3,4, Rosa Toenges, MD^1,2,3*, Jean-Baptiste Alberge, PhD^1,2,3, Michelle P. Aranha, PhD^1,2,3*, Ting Wu, MS^1*, Michael Timonian, MD^2,5*, Shonali Midha, MD^2*, Elizabeth K. O'Donnell, MD², Yuxin Liu, MD², Sophie Magidson, BS^2*, Ashlee Strutevant^2*, Kenneth C. Anderson, MD², Nikhil C. Munshi, MD², Omar Nadeem, MD², Gad Getz, PhD^1,3,6* and Irene Ghobrial, MD^1,2,3

¹Broad Institute of MIT and Harvard, Cambridge, MA
²Dana-Farber Cancer Institute, Boston, MA
³Harvard Medical School, Boston, MA
⁴Dana-Farber Cancer Institute, Brookline, MA
⁵St. Mary Medical Center, Long Beach, CA
⁶Krantz Family Center for Cancer Research and Dept. of Pathology, Massachusetts General Hospital, Boston, MA

Noemi Puig, PhD^1,2, Cristina Agullo^2*, Bruno Paiva, PhD^3,4,5,6*, María T Cedena^7*, Laura Rosiñol Dachs^8,9,10*, Teresa Contreras^11*, Joaquín Martínez-Lopez^12,13*, Albert Oriol^14,15*, María-Jesús Blanchard, MD, PhD^16,17*, Rafael Rios Tamayo, MD, PhD^18*, Ana Maria Sureda Balari, MD, PhD^{19,20,21,22,23,24,25,26,27}, Miguel Teodoro Hernández Garcia, MD, PhD^28*, Javier de la Rubia^29,30*, Valentin Cabanas Perianes, MD, PhD^31*, Felipe De Arriba, MD, PhD^32*, Luis Palomera, MD, PhD^33*, Maria Belen Inigo Rodriguez^34*, Veronica Gonzalez-Calle, MD, PhD^2,4,35,36*, Enrique M Ocio, MD, PhD^37*, Sergio Castro^2*, Joan Bargay^38*, Joan Bladé, MD, PhD^39,40*, Jesús F. San-Miguel, MD, PhD^41,42, Juan-Jose Lahuerta Palacios, MD, PhD^43,44* and Maria- Victoria Mateos^45,46,47,48

¹Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain
²Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), University of Salamanca, Salamanca, Spain
³Cancer Center Clinica Universidad de Navarra (CCUN)., Pamplona, Spain
⁴Centro de Investigación Biomédica en Red en Cáncer (CIBERONC), Madrid, Spain
⁵Department of Hematology, Centre for Applied Medical Research, Cancer Center Clinica Universidad de Navarra, University of Navarra, IdiSNA, CIBERONC, Pamplona, Spain
⁶Clinica Universidad de Navarra (CCUN), Center for Applied Medical Research (CIMA), IDISNA, CIBER-ONC, Pamplona, Spain
⁷University Hospital 12 de octubre, Madrid, Spain
⁸Hospital Clinic de Barcelona, IDIBAPS, Barcelona, Spain
⁹Hematology Department, Hospital Clinic de Barcelona and Insitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
¹⁰Hospital Clinic of Barcelona, Barcelona, Spain
¹¹Biochemistry Department, University Hospital of Salamanca, Salamanca, ESP
¹²Hospital Universitario 12 de octubre, Universidad Complutense, CNIO, Madrid, Spain
¹³University of Complutense, Hospital 12 de Octubre, Madrid, Spain
¹⁴Catalan Institute of Oncology and Josep Carreras Institute, Hospital Germans Trias i Pujol, Badalona, Spain
¹⁵Institut Josep Carreras and Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Barcelona, Spain
¹⁶Hematology, Hospital Universitario Ramón y Cajal, Madrid, Spain
¹⁷Hematology, Hospital Universitario Ramon y Cajal, Madrid, Spain
¹⁸Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, ESP
¹⁹Grupo Español de Trasplante Hematopoyético y Terapia Celular (GETH-TC), Spain, Spain
²⁰Hematology, Institut Català d'Oncologia-Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona, Spain
²¹Institut Catala d’Oncologia, Barcelona, Spain
²²Biomedical Research Institute, Universitat de Barcelona, Barcelona, Spain
²³Blood Cell Barcelona Hematology Institute, Barcelona, Spain
²⁴Grupo Español de Trasplante Hematopoyético y Terapia Celular (GETH-TC), Madrid, Spain
²⁵EBMT Lymphoma Working Party, Paris, France
²⁶for the Lymphoma Working Party of the EBMT, Barcelona, Spain
²⁷Institut Català d'Oncologia-Hospital Duran i Reynals, Hospitalet del Llobregat, Spain
²⁸Hospital Universitario de Canarias, La Laguna, ESP
²⁹Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
³⁰Hospital Universitario y Politécnico La Fe, Valencia, Spain
³¹Hematology, IMIB-Virgen de la Arrixaca University Hospital, University of Murcia, El Palmar, Murcia, Spain
³²Hospital Morales Meseguer, IMIB-Arrixaca, Universidad de Murcia, Murcia, Spain
³³Hospital Clinico Universitario Lozano Blesa, Instituto Investigacion Sanitaria Aragon, Zaragoza, Spain
³⁴HOSPITAL CLINICO SAN CARLOS, MADRID, Spain
³⁵Haematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, Spain
³⁶University Hospital of Salamanca/IBSAL/Cancer Research Center-IBMCC (USAL-CSIC), CIBERONC, Salamanca, Salamanca, ESP
³⁷Hospital Universitario Marqués de Valdecilla (IDIVAL), Universidad de Cantabria, Santander, Spain
³⁸Hematology Department, Hospital Universitario Son Llàtzer. IdIsBa., Palma de Mallorca, Spain
³⁹Amyloidosis and Multiple Myeloma Unit, Department of Hematology, IDIBAPS, Hospital Clinic, Spain, Barcelona, Spain
⁴⁰Hospital Clinic, IDIBAPS, Barcelona, Spain
⁴¹Hematology and Cell Therapy Department. Clinica Universidad de Navarra, Instituto de Investigaciones Sanitarias de Navarra (IdiSNA), Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain
⁴²Clínica Universidad de Navarra, CIMA, IDISNA, CIBER-ONC (CB16/12/00369), Pamplona, Spain
⁴³Hematology, Hospital Universitario 12 de Octubre, Imas12, CIBERONC, Madrid, Spain
⁴⁴Hospital Universitario 12 de Octubre, CIBER-ONC CB16/12/00369, CNIO, Madrid, Spain
⁴⁵Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain, Salamanca, Spain
⁴⁶Hospital Universitario de Salamanca, Salamanca, Spain
⁴⁷Institute of Cancer Molecular and Cellular Biology, University Hospital of Salamanca, Salamanca, Spain
⁴⁸University of Salamanca, Department of Medicine, Salamanca, Spain

Ioannis Ntanasis-Stathopoulos, MD, PhD, MSc^1*, Ioannis V Kostopoulos, PhD^2*, Panagiotis Malandrakis, MD^1*, Pantelis Rousakis, Msc.^3*, Chrysanthi Panteli^3*, Evangelos Eleutherakis-Papaiakovou, MD^1*, Vasiliki Spiliopoulou, MD^1*, Georgia Dimitrakopoulou^3*, Despina Fotiou, MD^1*, Magdalini Migkou, MD^1*, Foteini Theodorakakou, MD^1*, Nikolaos Kanellias^1*, Maria Gavriatopoulou^1*, Efstathios Kastritis, MD, PhD^1*, Meletios A. Dimopoulos, MD¹, Ourania Tsitsilonis, MD, PhD^2* and Evangelos Terpos, MD, PhD⁴

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
²Department of Biology, School of Science, National and Kapodistrian University of Athens (NKUA), Athens, Greece
³Department of Biology, National and Kapodistrian University of Athens, School of Science, Athens, Greece
⁴Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Drosia, Attiki, Greece

Kentaro Narita, M.D.^1*, Youichi Machida^2*, Daisuke Ikeda^1,3*, Rikako Tabata, M.D.^1*, Atsushi Uehara, MD^1*, Mitsuaki Oura, M.D.^1*, Fuminari Fujii, M.D.^1*, Hajime Sakuma, M.D.^1*, Masami Takeuchi, M.D.^1* and Kosei Matsue, M.D., Ph.D.¹

¹Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan
²Department of Radiology, Kameda Medical Center, Chiba, JPN
³Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan

Rosa Toenges, MD^1,2,3*, Jean-Baptiste Alberge, PhD^1,2,3, Francesco Corrado, MD^4*, Nayda Bidikian, MD^3*, David M. Cordas Dos Santos, MD^3*, Ankit K. Dutta, PhD^3*, Elizabeth D. Lightbody, PhD^1,2,3, Romanos Sklavenitis Pistofidis, MD, PhD^3*, Adam S. Sperling, MD, PhD^3*, Kenneth C. Anderson, MD³, Shonali Midha, MD^5*, Yuxin Liu, MD³, Jacob P. Laubach^3*, Eric L. Smith, MD, PhD³, Nikhil C. Munshi, MD⁶, Omar Nadeem, MD³, Irene Ghobrial, MD^1,2,3 and Gad Getz, PhD^1,2,7*

¹Harvard Medical School, Boston, MA
²Broad Institute of MIT and Harvard, Cambridge, MA
³Dana-Farber Cancer Institute, Boston, MA
⁴Department of Medical Oncology, Jerome Lipper Center for Multiple Myeloma Research, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA
⁵Division of Hematologic Neoplasia, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁶Dana-Farber Cancer Institute, The Jerome Lipper Multiple Myeloma Center, Boston, MA
⁷Krantz Family Center for Cancer Research and Dept. of Pathology, Massachusetts General Hospital, Boston, MA